Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 22.02.
Forward PE Ratio (22.02) = Close Price ($858.90) / Consensus Forward EPS ($39.01)
FORWARD PE RATIO
22.02
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+10.57%
vs the sector median at left
McKesson Corporation
Market Cap
$100.56B
Forward PE Ratio
22.02
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| McKesson Corporation (MCK) | $100.56B | 22.02 |
| GSK plc (GSK)vs › | $105.00B | 14.65 |
| HCA Healthcare, Inc. (HCA)vs › | $92.92B | 14.54 |
| Elevance Health Inc. (ELV)vs › | $86.86B | 14.75 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $85.92B | 15.38 |
| CVS Health Corp. (CVS)vs › | $118.69B | 11.66 |
| Medtronic plc (MDT)vs › | $119.49B | 16.92 |
| Boston Scientific Corporation (BSX)vs › | $74.87B | 15.25 |
| Stryker Corporation (SYK)vs › | $126.30B | 21.93 |
| Cigna Corporation (CI)vs › | $73.33B | 9.10 |
Trailing P/E
23.0
reported TTM EPS
Forward P/E
22.0
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $39.01 implies +4.4% EPS growth vs the reported trailing $37.37.
At today's $858.90 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $44.61 | $44.26 – $45.21 | 9 | 19.3x |
| 2028-03-31 | $50.54 | $47.46 – $51.31 | 9 | 17.0x |
| 2029-03-31 | $57.77 | $55.68 – $59.61 | 3 | 14.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
